Poultry Vaccines Market Research Report – Forecast till 2027

Poultry Vaccines Market Size, Growth And Trends Analysis By Diseases (Infectious Bronchitis, Marek's Disease), Technology (Toxoid, Recombinant, Inactivated, Live Attenuated Vaccines (Lav)), Dosage Form (Duct, Liquid, Freeze Dried Vaccines) - Forecast Till 2027

ID: MRFR/HC/6046-HCR | February 2021 | Region: Global | 85 pages

Poultry Vaccines Market Scenario


The poultry vaccines market is accounted for USD 13,35.81 million in 2017 and expected to register ~ 7.25% CAGR during the forecast period (2018–2023).


Vaccination plays vital role in managing the health of poultry flock. There are many diseases that are prevented or reduced by vaccinating the poultry flock. vaccine helps to boost the bird’s immune system that produce antibodies, that allow birds body to fight again invading causal organisms.


The rising prevalence of animal diseases, increasing awareness about animal vaccination, growth in poultry population and outbreaks of poultry diseases, technological advancements, and improvement in government initiatives are boosting market growth. Moreover, rising demand for animal protein, improvement in productivity, and rising focus toward food safety are contributing boosting the growth of the market. For instance, in November 2018, MSD & Co. Inc. launched the INNOVAX-ND-IBD, the companies first live poultry vaccine in the US market.


The high cost associated with poultry vaccines, lack of awareness regarding poultry vaccines, and unaffordability of veterinary services in underdeveloped and developing regions may hamper the growth of the market during the assessment period. For instance, according to the National Institute of Standards and Technology (NIST), in January 2016, more than 35.0% of vaccines lost their potency during the global shipping, as they were stored at temperatures that were either too high or too low.


Segmentation


The global poultry vaccines market has been segmented on the basis of diseases, technology, dosage form and region.


On the basis of disease, the market has been classified as infectious bronchitis, avian influenza, marek's disease, newcastle disease, and others. the market, by technology, has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines (lav), and others. based on dosage form, the market has been segmented into duct vaccines, liquid vaccines, and freeze-dried vaccines.


The live attenuated vaccines segment is expected to hold the largest market share of the poultry vaccines market, by technology, during the forecast period. Also, recombinant vaccines segment to register the highest CAGR in the global poultry vaccines market during the forecast period.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The poultry vaccines market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European poultry vaccines market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The poultry vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The poultry vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Poultry Vaccines Market Share, by Region, 2017 (%)


Poultry Vaccines Market


Source: MRFR Analysis


The Americas are likely to dominate the global poultry vaccines market owing to the awareness about the prevention of animal-to-human transmission diseases, safe animal food supply, and rising investment in research and development for animal vaccines. Moreover, high expenditure spending on healthcare and the presence of veterinary hospitals coupled with favorable reimbursement rates in the US and Canada also fueling the growth of the market during forecast periods. For instants, according to the American Veterinary Medical Association, in 2018, around 6.9% of spending increased on veterinary care.


The European market is expected to be the second-largest poultry vaccines market. The market growth in this region can be attributed to the government support for research & development, increasing production of veterinary products, and improved animal husbandry practices.


Asia-Pacific is expected to be the fastest-growing poultry vaccines market during the forecast period owing to penetration of the veterinary sector, a surging number of private veterinary clinics, and increasing awareness about animal welfare in China, India, and Australia.


The market in the Middle East & Africa is expected to account for the smallest share of the global poultry vaccines market due to lack of skilled veterinarians, high cost of treatment, and poor medical facilities.


Key Players


Some of the key players in the global poultry vaccines market are Boehringer Ingelheim, Elanco, MSD & Co., Zoetis Inc, Ceva Animal Health Inc., Phibro Animal Health Corporation, Virbac, Hipra, Venkys, Biovet, and Anicon GmbH, and Others.


Poultry vaccines Market, by Diseases



  • Infectious bronchitis

  • Avian Influenza

  • Marek's Disease

  • Newcastle Disease

  • Others


Poultry vaccines Market, by Technology



  • Toxoid Vaccines

  • Recombinant Vaccines

  • Inactivated Vaccines

  • Live Attenuated Vaccines (LAV)

  • Others


Poultry vaccines Market, by Dosage Form



  • Duct Vaccines

  • Liquid Vaccines

  • Freeze Dried Vaccines


Poultry vaccines Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles    



  • Boehringer Ingelheim

  • Elanco

  • MSD & Co.

  • Zoetis Inc

  • Ceva Animal Health Inc.

  • Phibro Animal Health Corporation

  • Virbac

  • Hipra

  • Venkys

  • Biovet

  • Anicon GmbH

  • Others


Intended Audience



  • Veterinary vaccine products manufacturers and vendors

  • Research organization

  • Various research and consulting firms

  • Veterinary hospital

  • Animal health organization and association



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 13,35.81 Million
  • 2027: Significant Value
  •   CAGR   7.25% (2018-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Diseases, Technology, Dosage form
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Boehringer Ingelheim, Elanco, MSD & Co., Zoetis Inc, Ceva Animal Health Inc., Phibro Animal Health Corporation, Virbac, Hipra, Venkys, Biovet, and Anicon GmbH, and Others
      Key Market Opportunities

  • Rising demand for animal protein
  • Improvement in productivity
  • Rising focus toward food safety
  •   Key Market Drivers

  • Rising prevalence of animal diseases
  • Increasing awareness about animal vaccination
  • Growth in poultry population and outbreaks of poultry diseases
  • Technological advancements
  • Improvement in government initiatives


  • Speak to Analyst Ask for Customization

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    Chapter 3. Research Methodology

    3.1. Introduction

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation

    Chapter 4. Market Dynamics

    4.1. Drivers

    4.2. Restraints

    4.3. Opportunities

    4.4. Challenges

    4.5. Macroeconomic Indicators

    Chapter 5. Market Factor Analysis

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis

    5.3. Investment Feasibility Analysis

    5.4. Pricing Analysis

    Chapter 6. Global Poultry Vaccines Market, by Diseases

    6.1. Introduction

    6.2. Infectious bronchitis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3. Avian Influenza

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4. Marek's Disease

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5. Newcastle Disease

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6. Others

    Chapter 7. Global Poultry Vaccines Market, by Technology

    7.1. Introduction

    7.2. Toxoid Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3. Recombinant Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4. Inactivated Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5. Live Attenuated Vaccines (LAV)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.6. Others

    Chapter 8. Global Poultry Vaccines Market, by Dosage Form

    8.1. Introduction

    8.2. Duct Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3. Liquid Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4. Freeze Dried Vaccines

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5. Others

    Chapter 9. Global Poultry Vaccines Market, by Region

    9.1. Introduction

    9.2. Americas

    9.2.1. North America

    9.2.1.1. US

    9.2.1.2. Canada

    9.2.2. Latin America

    9.3. Europe

    9.3.1. Western Europe

    9.3.1.1. Germany

    9.3.1.2. France

    9.3.1.3. Italy

    9.3.1.4. Spain

    9.3.1.5. UK

    9.3.1.6. Rest of Western Europe

    9.3.2. Eastern Europe

    9.4. Asia-Pacific

    9.4.1. Japan

    9.4.2. China

    9.4.3. India

    9.4.4. Australia

    9.4.5. South Korea

    9.4.6. Rest of Asia-Pacific

    9.5. Middle East & Africa

    9.5.1. Middle East

    9.5.2. Africa

    Chapter 10. Company Landscape

    10.1. Introduction

    10.2. Market Share Analysis

    10.3. Key Developments & Strategies

    Chapter 11. Company Profiles

    11.1. Boehringer Ingelheim GmbH

    11.1.1. Company Overview

    11.1.2. Product Overview

    11.1.3. Financials Overview

    11.1.4. Key Developments

    11.1.5. SWOT Analysis

    11.1.6. Key Strategies

    11.2. Elanco

    11.2.1. Company Overview

    11.2.2. Product Overview

    11.2.3. Financials Overview

    11.2.4. Key Developments

    11.2.5. SWOT Analysis

    11.2.6. Key Strategies

    11.3. MSD & Co.

    11.3.1. Company Overview

    11.3.2. Product Overview

    11.3.3. Financials Overview

    11.3.4. Key Developments

    11.3.5. SWOT Analysis

    11.3.6. Key Strategies

    11.4. Zoetis Inc

    11.4.1. Company Overview

    11.4.2. Product Overview

    11.4.3. Financials Overview

    11.4.4. Key Developments

    11.4.5. SWOT Analysis

    11.4.6. Key Strategies

    11.5. Ceva Animal Health Inc.

    11.5.1. Company Overview

    11.5.2. Product Overview

    11.5.3. Financials Overview

    11.5.4. Key Developments

    11.5.5. SWOT Analysis

    11.5.6. Key Strategies

    11.6. Phibro Animal Health Corporation

    11.6.1. Company Overview

    11.6.2. Product Overview

    11.6.3. Financials Overview

    11.6.4. Key Developments

    11.6.5. SWOT Analysis

    11.6.6. Key Strategies

    11.7. Virbac

    11.7.1. Company Overview

    11.7.2. Product Overview

    11.7.3. Financials Overview

    11.7.4. Key Developments

    11.7.5. SWOT Analysis

    11.7.6. Key Strategies

    11.8. Hipra

    11.8.1. Company Overview

    11.8.2. Product Overview

    11.8.3. Financials Overview

    11.8.4. Key Developments

    11.8.5. SWOT Analysis

    11.8.6. Key Strategies

    11.9. Venkys

    11.9.1. Company Overview

    11.9.2. Product Overview

    11.9.3. Financials Overview

    11.9.4. Key Developments

    11.9.5. SWOT Analysis

    11.9.6. Key Strategies

    11.10. Biovet

    11.10.1. Company Overview

    11.10.2. Product Overview

    11.10.3. Financials Overview

    11.10.4. Key Developments

    11.10.5. SWOT Analysis

    11.10.6. Key Strategies

    11.11. Anicon GmbH

    11.11.1. Company Overview

    11.11.2. Product Overview

    11.11.3. Financials Overview

    11.11.4. Key Developments

    11.11.5. SWOT Analysis

    11.11.6. Key Strategies

    11.12. Others

    Chapter 12. MRFR Conclusion

    12.1. Key Findings

    12.1.1. From CEO’s View point

    12.1.2. Unmet Needs of the Market

    12.2. Key Companies to Watch

    12.3. Predictions for the Poultry Vaccines Industry

    Chapter 13. Appendix


    LIST OF TABLES

    Table 1. Global Poultry Vaccines Market Synopsis, 2020-2027

    Table 2. Global Poultry Vaccines Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3. Global Poultry Vaccines Market, by Region, 2020-2027 (USD Million)

    Table 4. Global Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 5. Global Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 6. Global Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 7. North America: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 8. North America: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 9. North America: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 10. US: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 11. US: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 12. US: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 13. Canada: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 14. Canada: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 15. Canada: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 16. Latin America: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 17. Latin America: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 18. Latin America: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 19. Europe: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 20. Europe: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 21. Europe: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 22. Western Europe: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 23. Western Europe: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 24. Western Europe: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 25. Eastern Europe: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 26. Eastern Europe: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 27. Eastern Europe: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 28. Asia-Pacific: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 29. Asia-Pacific: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 30. Asia-Pacific: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    Table 31. Middle East & Africa: Poultry Vaccines Market, by Diseases, 2020-2027 (USD Million)

    Table 32. Middle East & Africa: Poultry Vaccines Market, by Technology, 2020-2027 (USD Million)

    Table 33. Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1. Research Process

    Figure 2. Segmentation for Global Poultry Vaccines Market

    Figure 3. Segmentation Market Dynamics for Global Poultry Vaccines Market

    Figure 4. Global Poultry Vaccines Market Share, by Diseases, 2020

    Figure 5. Global Poultry Vaccines Market Share, by Technology, 2020

    Figure 6. Global Poultry Vaccines Market Share, by Dosage Form, 2020

    Figure 7. Global Poultry Vaccines Market Share, by Region, 2020

    Figure 8. North America: Poultry Vaccines Market Share, by Country, 2020

    Figure 9. Europe: Poultry Vaccines Market Share, by Country, 2020

    Figure 10. Asia-Pacific: Poultry Vaccines Market Share, by Country, 2020

    Figure 11. Middle East & Africa: Poultry Vaccines Market Share, by Country, 2020

    Figure 12. Global Poultry Vaccines Market: Company Share Analysis, 2020 (%)

    Figure 13. Boehringer Ingelheim GmbH: Key Financials

    Figure 14. Boehringer Ingelheim GmbH: Segmental Revenue

    Figure 15. Boehringer Ingelheim GmbH: Geographical Revenue

    Figure 16. Elanco: Key Financials

    Figure 17. Elanco: Segmental Revenue

    Figure 18. Elanco: Geographical Revenue

    Figure 19. MSD & Co.: Key Financials

    Figure 20. MSD & Co.: Segmental Revenue

    Figure 21. MSD & Co.: Geographical Revenue

    Figure 22. Zoetis: Key Financials

    Figure 23. Zoetis: Segmental Revenue

    Figure 24. Zoetis: Geographical Revenue

    Figure 25. Ceva Animal Health Inc.: Key Financials

    Figure 26. Ceva Animal Health Inc.: Segmental Revenue

    Figure 27. Ceva Animal Health Inc.: Geographical Revenue

    Figure 28. Phibro Animal Health Corporation: Key Financials

    Figure 29. Phibro Animal Health Corporation: Segmental Revenue

    Figure 30. Phibro Animal Health Corporation: Geographical Revenue

    Figure 31. Virbac: Key Financials

    Figure 32. Virbac: Segmental Revenue

    Figure 33. Virbac: Geographical Revenue

    Figure 34. Hipra: Key Financials

    Figure 35. Hipra: Segmental Revenue

    Figure 36. Hipra: Geographical Revenue

    Figure 37. Venkys: Key Financials

    Figure 38. Venkys: Segmental Revenue

    Figure 39. Venkys: Geographical Revenue

    Figure 40. Biovet: Key Financials

    Figure 41. Biovet: Segmental Revenue

    Figure 42. Biovet: Geographical Revenue

    Figure 43. Anicon GmbH: Key Financials

    Figure 44. Anicon GmbH: Segmental Revenue

    Figure 45. Anicon GmbH: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.